MarketInOut Stock Screener Log In | Sign Up
 

MaxCyte Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/14/2026 16:00
MaxCyte Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization134.16 mln
Float94.76 mln
Earnings Date11/11/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.11
Reliable

Relative Strength

96 / 100
Top performer

Debt / Equity

0.11
Very low leverage

Pre-Tax Margin

-115%
Severely loss-making

ROE

-20.50
Deeply negative

Business Description

MaxCyte is a Rockville, Maryland-based life sciences company that develops and sells advanced cell engineering technology used in drug discovery, biomanufacturing, and the development of cell-based therapies. Its core platform centers on electroporation instruments that allow researchers and manufacturers to introduce genetic material into cells at various scales, from small laboratory work to large commercial production. The company generates revenue by licensing its technology and selling both its instruments and the single-use components that support them to pharmaceutical, biotechnology, and cell therapy companies worldwide.

Key Fundamentals

EPS-0.35
ROE-20.50
RPS0.29
ROIC-37.38
ROA-17.56
EBITDA, mln-30.59
EV / EBITDA-0.92
EV / EBIT-0.79
Revenue, mln31.05
EV / Revenue0.90

Quote Details

Last 1.25
Change 0.2857 (29.63%)
Open 1.23
Volume 12,565,524
Turnover 15,706,905
Average Volume 908,157

Financial Ratios

Pre-Tax Profit Margin-115
Leverage Ratio1.16
Current Ratio12.26
Price / Book0.75
Price / Tangible Book0.75
Debt / Equity0.11
Price / Sales3.85

Financial Strength

Altman Z-Score0.99
Piotroski F-Score 2 / 9
Beneish M-Score-3.11
Short Ratio2.72
Short % of Float1.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 20.19% 99 / 100   
1 Month 5.04% 90 / 100   
2 Months -2.34% 53 / 100   
6 Months 47.89% 95 / 100   
1 Year -21.88% 29 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us